BGI Genomics
Bookmark
ShareBGI Genomics is a company. It is in Shenzhen, China and it has a male CEO called Lijian Zhao. It was founded in 1999 and is part of the Health Care sector, specifically in the Health Care Providers & Services industry.
Key facts
- city: Shenzhen
- country: China
- employees: Try Pro to see estimate
- revenues: 958.4M $
- sector: Health Care
- industry: Health Care Providers & Services
- foundation year: 1999
- CEO: Lijian Zhao
- CEO gender: male
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about BGI Genomics:
Stocks from BGI Genomics:
BGI Genomics is one of the companies in Lijian Zhao, companies in China, companies in Health Care Providers & Services, companies in Health Care and 3,584,319 companies in our database.
Talking Points
- 华大基因基因科技造福人类
- 华大基因作为中国基因行业的奠基者，秉承“基因科技造福人类”的使命，通过 20
- BGI Genomics Co., Ltd. provides sequencing services and a portfolio of genetic tests for medical institutions, research institutions, and other public and private partners in China and internationally. The company offers DNA, RNA, and customized sequencing services; and non-invasive prenatal testing, reproductive health screening, newborn genetic screening, and clinical exome sequencing services, as well as clinical and research solutions for oncology. It also offers laboratory solutions for the detection and diagnosis of patients suspected with COVID-19; SARS-CoV-2 IgM and IgG antibody detection kit; and real-time fluorescent RT-PCR kit for detecting SARS-CoV-2. The company offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company was formerly known as Shenzhen BGI Medicine Co., Ltd. and changed its name to BGI Genomics Co., Ltd. in 2015. BGI Genomics Co., Ltd. was founded in 1999 and is headquartered in Shenzhen, China.
